Recurrence of progressive skin involvement following discontinuation or dose reduction of Mycophenolate Mofetil treatment in patients with diffuse Systemic Sclerosis.

Mendoza, Fabian A; Lee-Ching, Cathy; Jimenez, Sergio A

Mendoza, Fabian A; Lee-Ching, Cathy; Jimenez, Sergio A.

Affiliation

Mendoza FA; Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA; Jefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University. Philadelphia, PA 19107, USA. Electronic address: fam002@jefferson.edu.
Lee-Ching C; Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Jimenez SA; Jefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University. Philadelphia, PA 19107, USA.

Semin Arthritis Rheum ; 50(1): 135-139, 2020 02.

Article de En | MEDLINE | ID: mdl-31311679

Sujet(s)
Mots clés

Mycophenolate; Relapse; Scleroderma; Systemic Sclerosis; Treatment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peau / Sclérodermie diffuse / Diminution progressive de la dose du médicament / Immunosuppresseurs / Acide mycophénolique Type d'étude: Clinical_trials Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Semin Arthritis Rheum Année: 2020 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google